• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24038 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     NIHR Health Technology Assessment programme A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
2014     HAYES, Inc. Intron A (Interferon alfa-2b, recombinant; Schering Corp., a Subsidiary of Merck & Co., Inc.) for treatment of bladder cancer
2014     NIHR Public Health Research (PHR) programme Crime, fear of crime and mental health: Synthesis of theory and systematic reviews of interventions and qualitative evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgical procedures for obese and morbidly obese patients: a review of comparative clinical and cost-effectiveness, and guidelines
2014     Penn Medicine Center for Evidence-based Practice (CEP) Oral versus intravenous antibiotics for pediatric oncology patients with fever
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Robotically assisted laparoscopic surgery for rectal cancer
2014     The Swedish Council on Health Technology Assessment (SBU) [Aromatase inhibitors for early-stage breast cancer]
2014     HAYES, Inc. Living related donor small bowel transplantation for intestinal failure
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014     Penn Medicine Center for Evidence-based Practice (CEP) Management of geriatric depression identified in the acute care setting
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Left Ventricular Assist Device as permanent support in patients with end-stage heart failure
2014     HAYES, Inc. NanoKnife System (AngioDynamics Inc.) for irreversible electroporation treatment of pancreatic cancer
2014     Norwegian Knowledge Centre for the Health Services (NOKC) [Effect of adapted interventions for primary child health care services]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014     Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Orthodontic retainers
2014     NIHR Health Technology Assessment programme Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review
2014     NIHR Health Technology Assessment programme Preparatory study for the Re-valuation of the EQ-5D Tariff
2014     HAYES, Inc. NanoKnife System (AngioDynamics Inc.) for irreversible electroporation treatment of primary and metastatic liver tumors
2014     Norwegian Knowledge Centre for the Health Services (NOKC) Gynecological consequences of female genital mutilation/cutting (FGM/C)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term use of ondansetron, dolasetron and granisetron for the prevention of nausea and vomiting: a review of the clinical effectiveness and safety
2014     Penn Medicine Center for Evidence-based Practice (CEP) Impact of physician specialty and hospital models of care on healthcare utilization in patients with sickle cell disease
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Pediatric robotically assisted surgery for pyeoloplasty and fundoplication
2014     HAYES, Inc. Computerized Neurocognitive Testing (CNT) for sports-related head injury
2014     HAYES, Inc. Noncontact low-frequency ultrasound using the mist therapy system (Celleration Inc.) for treatment of wounds
2014     Norwegian Knowledge Centre for the Health Services (NOKC) Immediate health consequences of female genital mutilation/cutting (FGM/C)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014     Penn Medicine Center for Evidence-based Practice (CEP) Interventions to reduce stress among nurses caring for patients with sickle cell disease
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Home-based versus hospital-based supervised exercise or walk advice as treatment for intermittent claudication
2014     NIHR Health Technology Assessment programme Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation the CASCADE study
2014     NIHR Health Technology Assessment programme Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study
2014     NIHR Health Technology Assessment programme A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely specific measures
2014     HAYES, Inc. High-frequency chest wall compression for diseases other than cystic fibrosis
2014     HAYES, Inc. Plasma exchange for treatment of steroid-refractory transverse myelitis
2014     Norwegian Knowledge Centre for the Health Services (NOKC) [The effect of infection control interventions in day-care facilities and schools]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014     Penn Medicine Center for Evidence-based Practice (CEP) Patient-controlled analgesia for management of acute sickle cell disease
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Botulinum toxin type A for prophylactic treatment of chronic migraine
2014     HAYES, Inc. Intrathecal opioids for chronic noncancer pain
2014     NIHR Health Technology Assessment programme Allopurinol for the treatment of chronic kidney disease: a systematic review
2014     HAYES, Inc. Zio Patch (iRhythm Technologies Inc.) for long-term ambulatory cardiac rhythm monitoring
2014     Norwegian Knowledge Centre for the Health Services (NOKC) [Effects of more than three months organized follow-up on physical activity and diet for people with increased risk of lifestyle related disease]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) BMI reduction and chronic disease management: clinical evidence
2014     Penn Medicine Center for Evidence-based Practice (CEP) Safety of renal biopsy for patients taking aspirin
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Psychological interventions to improve poor oral health in adults and adolescents
2014     NIHR Health Technology Assessment programme Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men
2014     HAYES, Inc. Intravenous immunoglobulin for rheumatic diseases
2014     NIHR Health Technology Assessment programme United Kingdom Oscillation Study: long-term outcomes of a randomised trial of two modes of neonatal ventilation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014     Penn Medicine Center for Evidence-based Practice (CEP) Risk factors for high resource utilization in patients with sickle cell disease
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Invasive ventilation in patients with Amyotrophic Lateral Sclerosis and respiratory failure
2014     NIHR Health Technology Assessment programme VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model
2014     Agency for Healthcare Research and Quality (AHRQ) Pharmacologic therapies for the management of Crohn's disease: comparative effectiveness
2014     HAYES, Inc. Intravenous vitamin C for the treatment of cancer
2014     NIHR Health Technology Assessment programme Death, Bereavement and randomised controlled trials (BRACELET): a methodological study of policy and practice in neonatal and paediatric intensive care trials
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suspended ceiling lifts: safety
2014     Penn Medicine Center for Evidence-based Practice (CEP) Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Surgical or endovascular intervention for aortic coarctation in adult native, residual or re-coarctation?
2014     NIHR Health Technology Assessment programme A randomised controlled trial and cost-effectiveness evaluation of booster interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods
2014     HAYES, Inc. Percutaneous mitral valve repair
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) OnabotulinumtoxinA (Botox - Allergan Inc.) indication: chronic migraine
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Sustainability of inpatient psychiatric rehabilitation for adults: systematic review]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014     Penn Medicine Center for Evidence-based Practice (CEP) Allocating nursing personnel across units: shift-to-shift staffing
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Intravenous immunoglobulin for post-polio syndrome
2014     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of measures related to the prevention of multiple falls in hospitalized elderly people]
2014     NIHR Health Technology Assessment programme Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study)
2014     HAYES, Inc. Positron Emission Tomography (PET) for metastatic melanoma
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine (Neupro - UCB Canada Inc.) indication: idiopathic Parkinson disease (early and advanced)
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Obinutuzumab (Gazyva®) for previously untreated patients with chronic lymphocytic leukaemia (CLL)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Anesthetic injections into the stellate ganglion for the treatment of hot flashes in women: a review of clinical and cost-effectiveness and guidelines
2014     The Regional Health Technology Assessment Centre (HTA-centrum) The use of teledermatology and teledermoscopy for referrals of patients with suspected skin cancer
2014     NIHR Health Technology Assessment programme Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation) study
2014     HAYES, Inc. Robotically assisted hysterectomy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Endobronchial valves in emphysema]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Miethke proSA® adjustable gravitational shunt for hydrocephalus
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Hemodialysis twice versus three times a week in patients with residual kidney function: quality of life, cardiovascular outcomes and mortality
2014     HAYES, Inc. Sensory integration therapy for non-autistic children
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Implantation of a permanent embolic protection in patients with non-valvular attrial fibrillation in left auricular appendage]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Junctional tourniquets for controlling hemorrhage from wounds in adults: a review of clinical effectiveness, cost-effectiveness, safety, and guidelines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Drug-eluting stents with CD34 antibodies for the treatment of coronary artery disease
2014     HAYES, Inc. Smoking cessation in patients with schizophrenia
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Stereotactic radiofrequency / SRFA SRFA in hepatocellular carcinoma and liver metastases]
2014     NIHR Health Technology Assessment programme KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Antiemetics for adults experiencing opioid-induced nausea: a review of clinical and cost-effectiveness, benefits and harms, and guidelines
2014     HAYES, Inc. The use of Information Communication Technology (ICT) to improve treatment adherence in patients with diabetes
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hyperthermic intraperitoneal chemotherapy]
2014     NIHR Health Services and Delivery Research programme A cross-sectional prevalence survey of psychotropic medication prescribing patterns in prisons in England
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Hearing protection fit testing systems: clinical and cost-effectiveness and guidelines
2014     HAYES, Inc. Transcranial direct current stimulation for depression
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous transluminal angioplasty (pta) with drug eluting stents in peripheral arterial disease, upper limb and thorax]
2014     Technology Assessment Unit of the McGill University Health Centre (MUHC) Islet transplantation in patients with Type 1 Diabetes Mellitus
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic and non-pharmacologic treatments for alcohol withdrawal in the outpatient setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines